WallStSmart

Wellchange Holdings Company Limited (WCT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 10486% more annual revenue ($258.90M vs $2.45M). ZEPP leads profitability with a -15.5% profit margin vs -154.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

WCT

Avoid

27

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.03

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for WCT.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

WCT2 strengths · Avg: 9.5/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

WCT4 concerns · Avg: 2.5/10
Market CapQuality
$5.83M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-51.3%2/10

ROE of -51.3% — below average capital efficiency

EPS GrowthGrowth
-3.1%2/10

Earnings declined 3.1%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : WCT

The strongest argument for WCT centers on Price/Book, Debt/Equity. Revenue growth of 12.9% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : WCT

The primary concerns for WCT are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

WCT profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 27/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Wellchange Holdings Company Limited

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Wellchange Holdings Company Limited (WCT) operates at the forefront of the healthcare and wellness industry, delivering innovative solutions aimed at improving consumer health and overall lifestyle. By leveraging advanced technology and adhering to sustainable practices, WCT offers a comprehensive portfolio of products and services that prioritize well-being. The company's robust focus on research and development, coupled with strategic partnerships, uniquely positions it to capitalize on the increasing global demand for health-focused solutions. As a result, WCT presents a compelling investment opportunity for institutional investors seeking to gain exposure to a rapidly expanding market.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?